Gujarat Organics Ltd

Gujarat Organics Ltd

None%
- close price
About

Gujarat Organics specializes in the synthesis of Organic chemicals, Intermediates and Fine chemicals. It is one of the Largest Manufacturers of Para Hydroxy Benzoic Acid and its derivatives namely Parabens.

  • Market Cap Cr.
  • Current Price
  • High / Low /
  • Stock P/E
  • Book Value
  • Dividend Yield %
  • ROCE 11.1 %
  • ROE 12.1 %
  • Face Value 10.0

Pros

Cons

  • Earnings include an other income of Rs.32.1 Cr.
  • Debtor days have increased from 56.4 to 71.1 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Chemicals Industry: Chemicals

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Jun 2013 Sep 2013
12.49 11.86 15.15
11.85 11.03 13.32
Operating Profit 0.64 0.83 1.83
OPM % 5.12% 7.00% 12.08%
0.28 8.62 0.53
Interest 0.40 0.31 0.41
Depreciation 0.52 0.45 0.47
Profit before tax 0.00 8.69 1.48
Tax % 1.50% 31.08%
0.07 8.58 1.02
EPS in Rs
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
18 29 36 39 41 45 53 55 48 50 56 85
19 27 34 36 39 44 50 52 49 50 55 84
Operating Profit -1 2 2 3 2 2 3 3 -1 -0 1 1
OPM % -5% 5% 6% 7% 6% 4% 6% 5% -2% -0% 2% 1%
2 4 6 7 9 11 13 17 21 26 31 32
Interest 1 1 1 2 1 2 2 2 1 1 1 3
Depreciation 1 1 1 1 2 2 2 2 2 2 2 9
Profit before tax -1 3 5 7 8 9 13 16 17 23 29 22
Tax % -19% -3% 5% 1% -1% -4% 3% 0% 10% 12% 8% -4%
-1 4 5 6 8 9 13 16 16 20 27 22
EPS in Rs
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 11%
5 Years: 10%
3 Years: 21%
TTM: 51%
Compounded Profit Growth
10 Years: 17%
5 Years: 7%
3 Years: 10%
TTM: -26%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: 19%
5 Years: 17%
3 Years: 16%
Last Year: 12%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
Equity Capital 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20
Reserves 11 14 19 26 34 43 56 70 86 107 133 156
12 16 13 15 16 14 14 8 5 7 10 50
8 6 6 4 7 6 5 6 7 8 17 24
Total Liabilities 31 37 39 45 57 64 75 85 98 122 160 230
12 14 13 14 16 17 19 17 18 31 31 96
CWIP 1 0 0 0 0 1 0 1 0 1 34 26
Investments 1 2 1 8 12 18 30 38 49 60 48 46
18 21 24 23 28 27 26 29 31 30 47 62
Total Assets 31 37 39 45 57 64 75 85 98 122 160 230

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
-4 -4 -1 -0 -1 1 2 -1 7 -8 7
-0 -0 5 -2 0 -2 -1 5 -5 2 -41
4 4 -3 1 1 0 0 -3 2 4 32
Net Cash Flow -0 0 1 -1 0 -0 1 -0 4 -2 -2

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
Debtor Days 76 70 42 49 58 56 38 54 64 55 43 71
Inventory Days 234 174 181 143 172 144 116 106 118 164 204 141
Days Payable 217 115 82 49 70 52 31 46 72 63 102 114
Cash Conversion Cycle 94 129 141 142 160 147 124 114 110 155 145 98
Working Capital Days 146 149 148 148 151 129 109 123 165 127 177 150
ROCE % -1% 17% 20% 22% 21% 20% 23% 23% 18% 20% 21% 11%

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents